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S26 Am J PBackground: Studies of breast cancer in women and laboratory studies provide evidence that
shift work involving circadian rhythm disruption is a probable human carcinogen. How-
ever, evidence linking shift work and other circadian disruption factors to prostate cancer risk is
limited.
Purpose: To examine associations of work schedule (i.e., rotating shift work, ﬁxed night and ﬁxed
afternoon/evening shift work); sleep duration; and insomnia frequency with prostate cancer
mortality.
Methods: The Cancer Prevention Study–II is a large prospective cohort study of U.S. adults.
Work schedule, sleep duration, insomnia frequency, and other information was self-reported in
1982. Among 305,057 employed men, aged Z29 years who were cancer free at baseline, there
were 4974 prostate cancer deaths during follow-up through 2010. In 2013, multivariable-
adjusted relative risks (RRs) and 95% CIs were computed using Cox proportional hazards
regression.
Results: Work schedule and insomnia frequency were not associated with risk of fatal prostate
cancer. Short sleep duration was associated with higher risk of prostate cancer during the ﬁrst 8 years
of follow-up, compared to 7 hours/night, the RRs (95% CIs) for 3–5 and 6 hours/night were 1.64
(1.06, 2.54), and 1.28 (0.98, 1.67), respectively. There was no association between sleep duration and
fatal prostate cancer during later follow-up.
Conclusions: These results do not support associations of work schedule or insomnia frequency
with prostate cancer mortality. The association between short sleep duration and higher risk of fatal
prostate cancer only during the ﬁrst 8 years of follow-up suggests that short sleep duration could
affect later stages of prostate carcinogenesis.
(Am J Prev Med 2014;46(3S1):S26–S33) & 2014 American Journal of Preventive MedicineOpen access under CC BY-NC-ND license.IntroductionShift work is a method of organizing work schedulesthat includes hours other than ﬁxed daytime hoursand often results in exposure to light at night and
circadian rhythm disruption. An expert panel organized
by the International Agency for Research on Cancer
(IARC) in 2007 concluded that “shiftwork that involves
circadian disruption is probably carcinogenic to
humans.”1 This conclusion was based on studies of femaledemiology Research Program, American Cancer Society,
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Open access undnight shift workers and ﬂight attendants employed at least
10 years showing increased risk of breast cancer, and on
animal studies supporting a carcinogenic effect for light
exposure during the daily dark period.
The IARC panel also noted that “evidence related
to the role of circadian rhythm disruption in causing
prostate cancer is weak.”1 Recently, Sigurdardottir et al.2
reviewed the epidemiologic evidence on circadian dis-
ruption and prostate cancer risk. Although most early
studies of male airline pilots were suggestive of signiﬁcant
positive trends between number of long-haul ﬂights and
prostate cancer incidence, results of other studies com-
paring prostate cancer incidence rates in men employed
in rotating or night shift work to men in the general
population or between occupations where at least 40% of
employees work rotating shifts and occupations where
less than 30% work rotating shifts were inconsistent.rican Journal of Preventive Medicine  Published by Elsevier Inc.
er CC BY-NC-ND license.
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signiﬁcant higher risks of prostate cancer associated with
rotating shift work and night shift work. The only study
of sleep duration in relation to risk showed an inverse
association.6 Further, in an ecologic analysis of associa-
tions of light at night exposure (as estimated using GIS
methods from satellite images of nighttime illumination)
with age-standardized colorectal, lung, and prostate
cancer incidence rates across 164 countries, only the
association with prostate cancer incidence was signiﬁ-
cant.7 A causal association between shift work and
circadian rhythm disruption and prostate cancer risk is
biologically plausible and could be due, in part, to
suppression of melatonin, a hormone secreted by the
pineal gland that reduces the growth rate of prostate
cancer in vivo and in vitro.8
Although results of epidemiologic studies of circadian
disruption–related factors and prostate cancer risk are
intriguing, some limitations should be considered. First,
studies of shift work comparing men in speciﬁc occupa-
tions to the general population should be interpreted
cautiously because of higher screening rates in employed
men. Second, studies of total prostate cancer might be
less relevant because many prostate cancers detected
through screening would never have become clinically
apparent. Third, in the only published prospective cohort
study of rotating shift work and prostate cancer risk,5
there were only 31 total cases, and therefore results could
be due to chance. Additionally, the IARC panel noted the
need for further research on factors that affect circadian
rhythm such as sleep duration and quality.9
The Cancer Prevention Study–II (CPS–II) is a large,
long-term prospective cohort study of cancer mortality in
which self-reported information on work schedule, sleep
duration, and frequency of insomnia was collected in
1982 and has been followed for cause-speciﬁc mortality
through 2010.10 Using data collected from more than
305,000 employed men in this cohort, in 2013 associa-
tions of work schedule, sleep duration and insomnia
frequency with prostate cancer mortality were examined.
Sensitivity analyses examining associations stratiﬁed on
follow-up period, and excluding men who reported
frequent or painful urination, were conducted. Corrob-
oration of associations of circadian rhythm–related
factors with fatal prostate cancer risk in this cohort
would strengthen the evidence that circadian disruption
is a carcinogen in men.
Methods
The Cancer Prevention Study–II Cohort
Detailed methods for the enrollment of participants and data
collection in the CPS–II were reported previously.10 Brieﬂy, CPS–March 2014II was designed to identify risk factors for cancer and ways to
prevent it. Approximately 77,000 American Cancer Society (ACS)
volunteers in all 50 U.S. states, the District of Columbia, and
Puerto Rico invited their friends, neighbors, and relatives to
complete a four-page self-administered questionnaire that queried
participants for information on demographic, medical, occupa-
tional, and behavioral factors; dietary intake of major food groups;
height and weight; and a detailed history of current and past use of
cigarettes (and in men cigars, pipes, and smokeless tobacco).
Nearly 1.2 million adults (508,227 men) were enrolled in 1982 and
1983. The CPS–II is approved by the IRB of Emory University.
Men were excluded from analysis if they reported a history of
cancer other than nonmelanoma skin cancer (n¼25,232); reported
no current occupation at the time they completed the question-
naire in 1982 (n¼138,009); left rotating shift work blank
(n¼26,833); and among nonrotating shift workers, if they did
not report the time they started work (n¼13,096). A total of
305,057 men were included in this analysis.
Assessment of Work Schedule, Sleep Duration,
Insomnia Frequency, and Other Risk Factors
The 1982 CPS–II baseline self-administered questionnaire queried
participants for information on current occupation, and partic-
ipants were asked, Do you work rotating shifts? and What time of
day do you start working? The rotating shift work and time-of-day
variables were combined to create a ﬁve-level variable for work
schedule. Men who responded yes to working rotating shifts were
classiﬁed as rotating shift workers whereas, consistent with the
hours of shift work described by McMenamin,11 ﬁxed day workers
(reference group) were those who responded “no” to working
rotating shifts and reported starting work during the hours of
6:00AM to 10:00AM; ﬁxed afternoon/evening workers reported
starting work during the hours of 2:00PM to 4:00PM; ﬁxed night
workers reported starting work during the hours of 9:00PM to
12MN; and all other nonrotating shift workers were classiﬁed as
“other.”
The 1982 questionnaire also included the questions On the
average, how many hours do you sleep each night? and On the
average, how many times per month do you have insomnia? Sleep
duration was categorized as 3–5, 6, 7 (reference), 8, 9, and 10–12
hours/night; men were classiﬁed as missing if they did not respond
to the question or if they reportedr2 orZ13 hours/night because
these values were considered implausible. Consistent with previous
publications of insomnia and death from this cohort,12 the
frequency of insomnia was classiﬁed as never; infrequent or 1, 2,
3–9, and Z10 nights/month; or missing if left blank.
Mortality Follow-up
Vital status of CPS–II participants was determined using two
approaches. First, in September 1984, 1986, and 1988, ACS
volunteers made personal inquiries to determine whether the
participants they had enrolled were alive or dead, and then they
recorded the dates and places of deaths. Reported deaths were
veriﬁed by obtaining death certiﬁcates. At completion of the 1988
follow-up, vital status was known for 98.2% of the cohort.
Subsequently, linkage to the National Death Index (NDI) was
used to identify deaths that occurred from September 1988
through December 2010, and to identify deaths among the
Gapstur et al / Am J Prev Med 2014;46(3S1):S26–S33S2821,704 participants lost to follow-up between 1982 and 1988.
Death certiﬁcates or codes for cause of death were obtained for
more than 99% of all known deaths. A death was counted as a
prostate cancer death if the underlying cause of death was coded as
prostate cancer (ICD-9 code 185 and ICD-10 code C61).13,14
Among the 305,057 men included in this analysis, 4974 died of
prostate cancer during follow-up through 2010.
Statistical Analysis
Means and distributions of sociodemographic and other factors
across categories of work schedule, sleep duration, and frequency
of insomnia were examined to assess potential confounding.
Person-years of follow-up were computed for each participant as
the amount of time since completion of the baseline questionnaire
until date of death or until December 31, 2010. Cox proportional
hazards regression15 was used to compute multivariable-adjusted
relative risks (RRs) and 95% CIs to examine associations with work
schedule, sleep duration, and insomnia frequency. All models were
adjusted for age using the stratiﬁed Cox procedure. Multivariable-
adjusted models included dummy variables for race, education,
BMI, smoking history, family history of prostate cancer, and
frequent or painful urination. Although prescription sleeping pill
use was associated with sleep duration and insomnia, it was not
associated with risk of fatal prostate cancer and did not confound
the associations of work schedule, sleep duration, or insomnia
frequency with risk in this study; therefore it was not included in
the ﬁnal models. P values for trends were determined using the
median value within categories for sleep duration and insomnia
frequency. Additional multivariable models mutually adjusted for
all of the main exposure variables but results were unchanged and
therefore are not presented.
A sensitivity analysis stratiﬁed on follow-up time was con-
ducted. Multivariable-adjusted RRs (95% CIs) for the main
exposure variables were compared between the follow-up time
from 1982 through 1990, 1991 through 2000, and 2001 through
2010; results for the latter two follow-up times were nearly
identical and therefore were combined (data not shown). There-
fore, effect modiﬁcation by follow-up time from 1982 to 1990 and
1991 to 2010 was assessed by computing p-values for multi-
plicative interactions using likelihood ratio tests comparing Cox
multivariable models with and without cross-product terms for
categories of the main exposure variables and follow-up time. To
address possible reverse causality, sensitivity analyses excluding
the ﬁrst 3 years of follow-up and men who reported frequent or
painful urination were conducted. All analyses were performed
using Statistical Analysis Software (SAS, version 9.2), and all tests
of signiﬁcance are two-sided, with the level of signiﬁcance set at
po0.05.
Results
Among participants included in this analysis, nearly 6%
worked rotating shifts, 1% worked a ﬁxed afternoon/
evening shift, and 0.5% worked a ﬁxed night shift
(Table 1). Men who worked ﬁxed day shifts were slightly
older and had a lower BMI than men who worked other
shifts. The proportion of men who reported working a
ﬁxed day shift was lowest among men who were black,did not complete high school, were not currently
married, and were current/former smokers. There were
no meaningful associations of family history of prostate
cancer or frequency/painful urination with work sched-
ule. As expected, men employed in the emergency/
security, food service, janitorial/maintenance, manufac-
turing, and transportation industries were less likely to
report working a ﬁxed day shift than men in other
industries/occupations. For sleep duration (Appendix A,
available online at www.ajpmonline.org), men who
reported fewer hours/night of sleep were younger and
experienced more frequent insomnia. In addition, a
higher proportion of men who reported fewer hours of
sleep were black, had a lower education, were not
currently married, were current or ever smokers, expe-
rienced frequent/painful urination, and worked ﬁxed
night shifts. Men with frequent/painful urination were
more likely to report insomnia than other men
(Appendix B, available online at www.ajpmonline.org).
In age-adjusted adjusted analyses, rotating and ﬁxed
afternoon/evening shift work, but not ﬁxed night work,
were associated with a signiﬁcantly higher risk of fatal
prostate cancer compared to ﬁxed day work (Table 2).
After adjustment for race, education, frequent/painful
urination and other risk factors, the RRs were attenuated
and no longer signiﬁcant. Neither sleep duration nor
frequency of insomnia was associated with prostate
cancer mortality in either the age- or multivariable-
adjusted analyses.
In sensitivity analyses stratiﬁed on follow-up time,
there were no associations of work schedule or insomnia
with prostate cancer mortality for either follow-up period
from 1982 through 1990 or 1991 through 2010 (Table 3).
However, during follow-up from 1982 through 1990
there was an inverse association between sleep duration
and risk. Compared to 7 hours/night of sleep, there was a
64% higher risk of fatal prostate cancer associated with
3–5 hours/night and a 28% higher risk associated with
6 hours/night (ptrend¼0.05). There was no evidence of an
association between sleep duration and prostate cancer
mortality for the follow-up time from 1991 to 2010. The
test for interaction between sleep duration and follow-up
time was borderline signiﬁcant (pinteraction¼0.05). After
excluding the ﬁrst 3 years of follow-up time from
analyses of the 1982 through 1990 follow-up period,
the RRs (95% CIs) for 3–5, 6, 8, 9, and 10–12 hours/night
compared to 7 hours/night were 1.78 (1.14, 2.78); 1.30
(0.99, 1.72); 1.05 (0.83, 1.32); 0.90 (0.55, 1.48); and 1.13
(0.50, 2.57), respectively (ptrend¼0.03). Analyses were
repeated after excluding men who reported frequent/
painful urination (a potential cause of short sleep
duration and a symptom of prostate cancer) and results
were unchanged (data not shown).www.ajpmonline.org
Table 1. Characteristics by work schedule in the Cancer Prevention Study–II, % unless otherwise noted
Work schedule
Variable Na
Fixed day
(n¼274,702)
Rotating
(n¼18,126)
Fixed afternoon/
evening (n¼2921)
Fixed night
(n¼1612)
Other ﬁxed shift
(n¼7696)
Age (years; M [SD]) 305,057 53.4 (7.8) 51.4 (8.5) 52.4 (8.4) 51.9 (9.0) 53.2 (8.8)
BMI (M [SD]) 299,385 26.0 (3.3) 26.5 (3.7) 26.3 (3.7) 26.7 (3.9) 26.6 (3.9)
Sleep duration
(hours/night;
M [SD])
302,350 7.2 (0.9) 7.1 (1.1) 7.2 (1.1) 6.8 (1.3) 6.9 (1.2)
Insomnia (nights/
week; M [SD])
294,495 1.0 (2.9) 1.0 (3.0) 0.8 (2.6) 0.9 (3.0) 0.9 (3.0)
Race
White 288,738 90.6 5.7 0.9 0.5 2.4
Black 9,387 78.0 12.7 2.6 1.5 5.2
Other 6,932 85.3 8.9 1.4 0.7 3.8
Education
oHigh school 31,571 81.6 9.6 2.2 1.2 5.5
High school 58,781 84.4 9.0 1.6 0.8 4.1
Some college 82,657 88.3 7.2 1.2 0.6 2.7
College grad 129,995 95.9 2.8 0.2 0.2 0.9
Missing 2,053 84.6 9.3 1.3 0.9 4.0
Currently married
No 14,921 85.8 8.0 1.6 0.8 3.8
Yes 288,839 90.3 5.8 0.9 0.5 2.5
Missing 1,297 85.2 9.3 1.1 0.9 3.5
Smoking status
Never 80,441 91.3 5.1 0.7 0.5 2.4
Former 110,709 91.1 5.4 0.9 0.4 2.1
Current 80,132 87.3 7.5 1.3 0.8 3.1
Ever 3,008 83.1 11.0 1.0 0.8 4.1
Cigar/pipe 24,276 91.7 4.9 0.6 0.4 2.3
Missing 6,491 86.9 7.6 1.1 0.5 3.8
Family history of prostate cancer
No 296,194 90.0 6.0 1.0 0.5 2.5
Yes 8,863 91.1 5.1 0.8 0.4 2.6
Painful/frequent urination in last month
No 289,140 90.0 5.9 1.0 0.5 2.5
Yes 15,917 90.0 5.9 1.1 0.4 2.5
Industry/occupation
Agriculture 11,586 90.3 2.8 0.1 0.1 6.6
(continued on next page)
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Table 1. Characteristics by work schedule in the Cancer Prevention Study–II, % unless otherwise noted (continued)
Work schedule
Variable Na
Fixed day
(n¼274,702)
Rotating
(n¼18,126)
Fixed afternoon/
evening (n¼2921)
Fixed night
(n¼1612)
Other ﬁxed shift
(n¼7696)
Construction 12,004 92.9 4.4 0.9 0.4 1.5
Education 19,246 97.0 1.7 0.2 0.1 1.0
Emergency/
security
4,023 46.6 42.6 3.5 3.1 4.3
Engineering 16,945 95.8 3.0 0.3 0.1 0.7
Food service 1,403 62.9 15.3 3.0 1.9 17.0
Healthcare 16,382 87.3 10.0 0.7 0.5 1.4
Janitorial/
maintenance
5,548 80.7 6.4 4.9 1.8 6.2
Management 65,686 93.9 3.6 0.5 0.3 1.7
Manufacturing 10,335 82.8 10.4 3.0 1.0 2.8
Retail 25,404 91.8 4.7 0.4 0.4 2.7
Transportation 14,660 80.2 10.4 2.0 1.1 6.3
Other/unknown 101,835 89.7 6.2 1.0 0.6 2.4
aTotal number of participants for each variable may not add to 305,057 because of missing data.
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In this large prospective study, there was no evidence that
work schedule or frequency of insomnia were associated
with fatal prostate cancer. Although there was no
relationship between sleep duration and risk during the
full 28-year follow-up time, compared to 7 hours/night of
sleep, there was a signiﬁcant 64% higher risk associated
with 3–5 hours/night and a borderline signiﬁcant 28%
higher risk associated with 6 hours/night during the ﬁrst
8 years of follow-up.
Most epidemiologic studies of rotating or night shift
work and prostate cancer risk have been occupational
studies, and results of those studies are inconsistent.2
However, case–control studies of shift work have shown
signiﬁcant higher risks of prostate cancer among rotating
shift workers3 and night workers4 compared to ﬁxed day
workers. Similarly, a Japanese prospective study5 showed
a signiﬁcant threefold higher risk of prostate cancer
associated with rotating shift work compared to day work
and the risk associated with ﬁxed night shift also was
elevated although not signiﬁcant. However, there were
only 31 total prostate cancer cases in that study and
associations with advanced or metastatic disease were not
examined. In this CPS–II analysis, which included nearly
5000 fatal prostate cancer cases, there was no association
with work schedule after adjustment for confounding
factors. The absence of an association between workschedule and fatal prostate cancer in CPS–II, despite its
large size, might be due to the fact that no information
was available on speciﬁc aspects of shift work such as
duration or individual adaptability to rotating or night
shift work. Therefore, possible associations with long
duration of shift work or among individuals less able to
adapt to shift work cannot be ruled out.
In CPS–II, frequency of insomnia was not related to
fatal prostate cancer risk; no other study has examined
this relationship. It is possible that the insomnia fre-
quency might not adequately measure sleep quality.
Further research using more detailed measures is needed
to understand whether sleep quality is associated with
risk. For example, a recent study showing a positive
association between insomnia and risk of thyroid cancer
in women used an insomnia score that was based on ﬁve
questions related to insomnia, early morning awakening,
and sleep latency, maintenance, and quality.16
Short sleep duration was associated with higher risk of
fatal prostate cancer during the ﬁrst 8 years of follow-up
in CPS–II. These results are similar to the only one other
study that examined this association.6 In a cohort study
including 22,320 Japanese men, only 127 developed
prostate cancer during 6 years of follow-up, and the RR
between short sleep duration (i.e., for 4–6 hours/night
compared to 7–8 hours/night) and overall prostate
cancer risk was 1.38 (95% CI¼0.77, 2.48), whereas forwww.ajpmonline.org
Table 2. Age- and multivariable-adjusted associations of circadian rhythm–related factors and fatal prostate cancer
Variable N deathsa Person-years
Age-adjusted RR
(95% CI)
Multivariable-adjustedb
RR (95% CI)
Work schedule
Fixed day 4497 6,465,182 1.00 1.00
Rotating 268 422,487 1.13 (1.00, 1.28) 1.08 (0.95, 1.22)
Fixed afternoon/evening 55 65,955 1.35 (1.04, 1.76) 1.27 (0.97, 1.65)
Fixed night 16 36,017 0.78 (0.47, 1.27) 0.72 (0.44, 1.18)
Sleep duration (hours/night)
3–5 155 223,835 1.10 (0.93, 1.29) 1.03 (0.87, 1.21)
6 801 1,206,882 1.04 (0.96, 1.13) 1.01 (0.93, 1.10)
7 (ref) 1859 2,833,291 1.00 1.00
8 1842 2,515,594 1.05 (0.98, 1.12) 1.04 (0.98, 1.11)
9 226 263,463 1.12 (0.98, 1.29) 1.10 (0.96, 1.26)
10–12 46 59,435 1.02 (0.76, 1.37) 0.97 (0.72, 1.30)
ptrend¼0.61 ptrend¼0.32
Frequency of insomnia (nights/month)
Never 3578 5,130,613 1.00 1.00
1 280 503,331 0.86 (0.76, 0.97) 0.87 (0.77, 0.99)
2 340 490,252 1.04 (0.93, 1.16) 1.05 (0.94, 1.17)
3–9 453 642,871 1.01 (0.92, 1.12) 1.02 (0.93, 1.13)
Z10 123 160,897 1.04 (0.87, 1.25) 1.06 (0.88, 1.27)
ptrend¼0.56 ptrend¼0.40
aTotal number of deaths for each exposure variable do not add to 4974 because results for the categories “other” for work schedule and “missing” for
sleep duration or frequency of insomnia are not included in the table.
bMultivariable models are adjusted for age, race, education, BMI, smoking status, family history of prostate cancer, and painful/frequent urination.
RR, relative risk
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CI¼0.82, 4.05).
It is unclear why short sleep duration was associated
with a higher risk of fatal prostate cancer in CPS–II only
during the ﬁrst 8 years of follow-up. Reverse causality
appears unlikely because the elevated RRs for short sleep
duration were unchanged when the ﬁrst 3 years of
follow-up and men who reported frequent/painful uri-
nation were excluded. Because the ﬁrst 8 years of follow-
up (i.e., 1982–1990) preceded widespread screening for
prostate cancer using prostate-speciﬁc antigen (PSA)
testing, confounding by PSA screening also is unlikely
to explain the elevated RRs observed. However, chance
and confounding by unmeasured factors associated with
both short sleep duration and prostate cancer mortality
cannot be ruled out. Reasons for the lack of association
between sleep duration and prostate cancer mortality
during the later follow-up period are unclear. It isMarch 2014possible that short sleep duration promotes later stages
of prostate carcinogenesis but has little effect on earlier
stages.
The biologic mechanism underlying a possible associ-
ation between short sleep duration and a higher risk of
fatal prostate cancer is likely complex and not fully
understood. Short sleep duration can affect the circadian
clock resulting in the dysregulation of a number of genes
involved in tumor suppression.17 Sleep deprivation and
the associated presence of light at night can inhibit the
production of melatonin,18 and a link between melatonin
and carcinogenesis was recognized at least 30 years ago.19
Suppression of melatonin could result in increased
mutagenesis and oxidative damage, reduced DNA repair,
and enhanced immune suppression with a shift in
the regulation of inﬂammatory cytokines to those more
likely to promote cancer.20,21 For prostate cancer, mel-
atonin inhibits cell proliferation and/or induces cell
Table 3. Multivariable-adjusted associations of circadian rhythm–related factors and fatal prostate cancer by follow-up time
Follow-up 1982–1990 Follow-up 1991–2010
Variable
N
deathsa
Person-
years
Multivariable-adjustedb
RR (95% CI)
N
deathsa
Person-
years
Multivariable-adjustedb
RR (95% CI)
Work schedule
Fixed day 420 2,219,117 1.00 4077 4,246,065 1.00
Rotating 20 146,040 0.81 (0.52, 1.28) 248 276,447 1.11 (0.97, 1.26)
Fixed afternoon/evening 5 23,507 1.09 (0.45, 2.65) 50 42,448 1.29 (0.97, 1.70)
Fixed night 1 12,872 0.40 (0.06, 2.87) 15 23,144 0.76 (0.46, 1.26)
Sleep duration (hours/night)
3–5 24 79,127 1.64 (1.06, 2.54) 131 144,708 0.96 (0.81, 1.15)
6 87 415,976 1.28 (0.98, 1.67) 714 790,906 0.99 (0.90, 1.08)
7 (reference) 150 958,612 1.00 1709 1,874,679 1.00
8 170 870,124 1.07 (0.86, 1.33) 1672 1,645,470 1.04 (0.97, 1.11)
9 20 95,188 0.89 (0.55, 1.42) 206 168,276 1.13 (0.98, 1.30)
10–12 7 22,473 1.14 (0.53, 2.45) 39 36,961 0.94 (0.69, 1.30)
ptrend¼0.05 ptrend¼0.09
Frequency of insomnia (nights/month)
Never 329 1,765,635 1.00 3249 3,364,978 1.00
1 15 168,545 0.55 (0.33, 0.92) 265 334,786 0.90 (0.80, 1.02)
2 25 166,750 0.86 (0.57, 1.30) 315 323,502 1.07 (0.95, 1.20)
3–9 53 221,472 1.26 (0.94, 1.69) 400 421,398 1.00 (0.90, 1.11)
Z10 9 56,280 0.77 (0.40, 1.50) 114 104,617 1.09 (0.90, 1.31)
ptrend¼0.94 ptrend¼0.36
aTotal number of deaths for each of the main exposure variables do not add to 4974 because results for the categories “other” for work schedule and
“missing” for sleep duration or frequency of insomnia are not included in the table.
bMultivariable models are adjusted for age, race, education, BMI, smoking status, family history of prostate cancer, and painful/frequent urination.
RR, relative risk
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insensitive prostate cancer cells in vitro.8,22 In the trans-
genic adenocarcinoma of mouse prostate (TRAMP)
model, physiologic doses of melatonin also showed
antiproliferative effects.8
The major strengths of this study include its prospec-
tive design, and very large, nationwide sample of
employed men. The strengths include the collection of
information on work schedule, sleep duration, and
frequency of insomnia, which allowed for a detailed
analysis of multiple factors related to circadian rhythm
disruption. Moreover, we were able to adjust for poten-
tially important confounding factors, including educa-
tion, smoking, obesity, and frequent or painful urination.
Despite these strengths, the principal limitations include
the use of self-reported information. However, thedistributions of circadian rhythm–related factors across
categories of race and industry/occupation were consis-
tent with those reported elsewhere.11,23 Because exposure
information was collected only once, it is unlikely to
reﬂect long-term patterns, and given the long follow-up
period, there is likely to be nondifferential misclassiﬁca-
tion of circadian rhythm–related factors over time,
potentially resulting in attenuated associations. Misclas-
siﬁcation over time is of concern since the men in this
study were employed, and during the long-follow-up
period many of them likely retired, which might affect
their sleep duration and quality and exposure to light
at night.
In summary, shift work and insomnia were not
associated with fatal prostate cancer in this large pro-
spective cohort study, whereas short sleep duration waswww.ajpmonline.org
Gapstur et al / Am J Prev Med 2014;46(3S1):S26–S33 S33associated with higher risk but only during the ﬁrst
8 years of follow-up. Further research is warranted to
conﬁrm and better understand the biologic basis for this
relationship.
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